Clarity Lab Solutions, LLC

Clarity Lab Solutions, LLC was paid $2.55M by Medicaid between Aug 2018 and Nov 2023, across 39 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 52% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Florida

Rank by total paid#24 of 225

Median peer was paid$74K

This provider vs. median35×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	10,006	$94K
2019	5,279	$73K
2020	60,162	$1.37M
2021	70,764	$655K
2022	70,674	$328K
2023	4,469	$23K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	52%	38,721	11,835	$1.33M
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	10%	7,571	3,535	$267K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	9.0%	49,061	3,558	$230K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	8.3%	9,099	5,896	$212K
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	4.0%	8,409	1,387	$102K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	2.4%	16,166	7,542	$61K
87799		1.8%	6,490	1,789	$45K
87900		1.4%	1,857	1,052	$35K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	1.2%	8,972	2,468	$31K
87581		1.1%	9,441	4,464	$29K
87486		1.1%	9,614	4,605	$28K
87481		<1%	5,529	1,864	$21K

27 more codes

87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	1,201	$18K
87640		<1%	5,992	$17K
87500		<1%	4,733	$17K
87653		<1%	4,898	$16K
87652		<1%	1,702	$13K
87641		<1%	2,687	$12K
87632		<1%	1,609	$12K
87186		<1%	4,560	$11K
87631		<1%	409	$8K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	2,061	$5K
87482		<1%	1,543	$5K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	2,979	$5K
87563		<1%	2,141	$3K
87503		<1%	3,517	$2K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	88	$2K
87634		<1%	2,077	$1K
87498		<1%	1,685	$1K
87532		<1%	1,683	$1K
87541		<1%	1,686	$1K
87496		<1%	1,685	$1K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	34	$1K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	246	$1K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	246	$1K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	246	$998.42
87551		<1%	410	$949.82
87471		<1%	285	$401.55
87150		<1%	21	$30.95

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGROSSMAN, YOSEF (OWNER)